source
- Merck's Lipfendra pill receives FDA approval as first oral PCSK9 cholesterol treatmentThe U.S. Food and Drug Administration approved Lipfendra, an oral medication from Merck that lowers low density lipoprotein cholesterol. The drug blocks the PCSK9 protein, making it the first pill…
- Merck secures US approval for the first oral PCSK9 cholesterol-lowering pill, edging out AstraZenecaMerck has received the United States regulatory clearance for an oral PCSK9 inhibitor, marking the first time a pill of this class has been approved for cholesterol management. The approval comes…